The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53.
BACKGROUND: The vaccinia-related kinase 1 (VRK1) protein, an activator of p53, can be proteolytically downregulated by an indirect mechanism, which requires p53-dependent transcription. PRINCIPAL FINDINGS: In this work we have biochemically characterized the contribution of several p53 transcription...
Main Authors: | Alberto Valbuena, Sandra Blanco, Francisco M Vega, Pedro A Lazo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2441436?pdf=render |
Similar Items
-
Downregulation of VRK1 by p53 in response to DNA damage is mediated by the autophagic pathway.
by: Alberto Valbuena, et al.
Published: (2011-02-01) -
Differential inhibitor sensitivity between human kinases VRK1 and VRK2.
by: Marta Vázquez-Cedeira, et al.
Published: (2011-01-01) -
VRK1 Kinase Activity Modulating Histone H4K16 Acetylation Inhibited by SIRT2 and VRK-IN-1
by: Eva Monte-Serrano, et al.
Published: (2023-03-01) -
VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system
by: Jonathan So, et al.
Published: (2022-10-01) -
Human VRK1 is an early response gene and its loss causes a block in cell cycle progression.
by: Alberto Valbuena, et al.
Published: (2008-01-01)